| RS2540576131 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540576238 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540577060 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540577678 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540577777 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540577829 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540577903 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540578061 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540578127 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540580216 |
FGFR2
|
Health Risk |
Likely pathogenic |
— |
| RS2540585995 |
HNRNPA1
|
Health Risk |
Pathogenic |
Finnish upper limb-onset distal myopathy, Finnish upper limb-onset distal myopathy |
| RS2540586309 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Distal myopathy, Distal myopathy |
| RS2540592837 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540592843 |
GLE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Lethal arthrogryposis-anterior horn cell disease syndrome, Lethal congenital contracture syndrome 1 |
| RS2540593392 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540593632 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540595215 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540596707 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540596874 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540597317 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540597400 |
TRAPPC9
|
Health Risk |
Pathogenic |
— |
| RS2540597433 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540601198 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540601547 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540602131 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540602169 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540608495 |
GLE1
|
Health Risk |
Likely pathogenic |
— |
| RS2540608553 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540608655 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540608979 |
GLE1
|
Health Risk |
Likely pathogenic |
— |
| RS2540619128 |
SIK3
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia, Krakow type |
| RS2540627297 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540627387 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540635374 |
CRADD
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial isolated arrhythmogenic right ventricular dysplasia, Intellectual disability |
| RS2540637438 |
GLE1
|
Health Risk |
Likely pathogenic |
— |
| RS2540640409 |
B4GALNT1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2540642539 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540642684 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540647541 |
GLE1
|
Health Risk |
Pathogenic |
Lethal congenital contractural syndrome Finnish type, Lethal congenital contractural syndrome Finnish type |
| RS2540647761 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540650379 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540654534 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2540657675 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2540658045 |
B4GALNT1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2540658466 |
B4GALNT1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2540661679 |
B4GALNT1
|
Health Risk |
Likely pathogenic |
— |
| RS2540664011 |
DIP2C
|
Health Risk |
Pathogenic |
— |
| RS2540667597 |
B4GALNT1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2540668608 |
B4GALNT1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 26, Hereditary spastic paraplegia 26 |
| RS2540668999 |
B4GALNT1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 26, Hereditary spastic paraplegia 26 |
| RS2540671184 |
AGO2
|
Health Risk |
Likely pathogenic |
Premature ovarian failure 3, Premature ovarian failure 3 |
| RS2540687833 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2540691084 |
AGO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lessel-Kreienkamp syndrome, Lessel-Kreienkamp syndrome |
| RS2540702114 |
FGD4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4H, Charcot-Marie-Tooth disease type 4H |
| RS2540704889 |
AGO2
|
Health Risk |
Likely pathogenic |
Lessel-Kreienkamp syndrome, Lessel-Kreienkamp syndrome |
| RS2540710558 |
NEUROG3
|
Health Risk |
Pathogenic |
— |
| RS2540722756 |
RPS26
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 10, Diamond-Blackfan anemia 10 |
| RS2540722766 |
RPS26
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2540722839 |
RPS26
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2540722911 |
RPS26
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia 10, Diamond-Blackfan anemia 10 |
| RS2540723571 |
RPS26
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2540723664 |
RPS26
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2540724145 |
RPS26
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2540724191 |
RPS26
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia 10, Diamond-Blackfan anemia 10 |
| RS2540726643 |
AGO2
|
Health Risk |
Likely pathogenic |
— |
| RS2540728555 |
KCNJ8
|
Health Risk |
Likely pathogenic |
— |
| RS2540729687 |
AGO2
|
Health Risk |
Likely pathogenic |
Lessel-Kreienkamp syndrome, Lessel-Kreienkamp syndrome |
| RS2540734022 |
SART3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Neurodevelopmental defects and Developmental delay with 46 |
| RS2540742315 |
ERBB3
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2540742712 |
SART3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Neurodevelopmental defects and Developmental delay with 46 |
| RS2540749216 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2540749877 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2540749923 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS2540750383 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS2540750688 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2540750877 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2540751147 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS2540752137 |
ST14
|
Health Risk |
Pathogenic |
— |
| RS2540753340 |
SART3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Neurodevelopmental defects and Developmental delay with 46 |
| RS2540755180 |
ST14
|
Health Risk |
Pathogenic |
— |
| RS2540756298 |
DAGLA
|
Health Risk |
Pathogenic |
Benign paroxysmal tonic upgaze of childhood with ataxia, Benign paroxysmal tonic upgaze of childhood with ataxia |
| RS2540756454 |
DAGLA;MYRF-AS1
|
Health Risk |
Likely pathogenic |
Autosomal dominant cerebellar ataxia, Autosomal dominant cerebellar ataxia |
| RS2540756474 |
DAGLA
|
Health Risk |
Pathogenic |
Benign paroxysmal tonic upgaze of childhood with ataxia, Benign paroxysmal tonic upgaze of childhood with ataxia |
| RS2540756572 |
DAGLA
|
Health Risk |
Pathogenic |
See cases, Benign paroxysmal tonic upgaze of childhood with ataxia |
| RS2540758398 |
ST14
|
Health Risk |
Pathogenic |
— |
| RS2540758459 |
ERBB3
|
Health Risk |
Likely pathogenic |
ERBB3-related disorder, ERBB3-related disorder |
| RS2540763693 |
ATP2B1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2540764901 |
PFKM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VII |
| RS2540765020 |
PFKM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type VII |
| RS2540786278 |
FGD4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2540791541 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1O |
| RS2540803653 |
ATP2B1
|
Health Risk |
Pathogenic |
— |
| RS2540803952 |
ATP2B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, ATP2B1-related disorder |
| RS2540804052 |
ATP2B1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2540804225 |
ATP2B1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 66 |
| RS2540804470 |
ATP2B1
|
Health Risk |
Likely pathogenic |
ATP2B1-related disorder, ATP2B1-related disorder |
| RS2540806316 |
ABCC9
|
Health Risk |
Likely pathogenic |
Hypertrichotic osteochondrodysplasia Cantu type, Hypertrichotic osteochondrodysplasia Cantu type |
| RS2540808944 |
FANCC
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group C, Fanconi anemia |
| RS2540809221 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group C |
| RS2540809415 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group C |